nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—MUC2—O-linked glycosylation—B3GLCT—age related macular degeneration	0.0718	0.0739	CbGpPWpGaD
Pranlukast—MUC2—O-linked glycosylation—ADAMTS9—age related macular degeneration	0.0463	0.0476	CbGpPWpGaD
Pranlukast—MUC2—Post-translational protein modification—B3GLCT—age related macular degeneration	0.033	0.034	CbGpPWpGaD
Pranlukast—NFKB1—Melatonin metabolism and effects—MAP2—age related macular degeneration	0.0245	0.0252	CbGpPWpGaD
Pranlukast—NFKB1—NF-kB is activated and signals survival—SQSTM1—age related macular degeneration	0.0231	0.0238	CbGpPWpGaD
Pranlukast—MUC2—Post-translational protein modification—ADAMTS9—age related macular degeneration	0.0213	0.0219	CbGpPWpGaD
Pranlukast—TNF—Matrix Metalloproteinases—TIMP3—age related macular degeneration	0.0204	0.0209	CbGpPWpGaD
Pranlukast—NFKB1—p75NTR signals via NF-kB—SQSTM1—age related macular degeneration	0.0196	0.0201	CbGpPWpGaD
Pranlukast—ABCC2—ABC-family proteins mediated transport—ABCG4—age related macular degeneration	0.0184	0.0189	CbGpPWpGaD
Pranlukast—IL5—Platelet activation, signaling and aggregation—SERPING1—age related macular degeneration	0.0165	0.017	CbGpPWpGaD
Pranlukast—ABCC2—ABC-family proteins mediated transport—ABCA4—age related macular degeneration	0.0164	0.0169	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—SKIV2L—age related macular degeneration	0.0157	0.0161	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—B3GLCT—age related macular degeneration	0.0157	0.0161	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—TIMP3—age related macular degeneration	0.0144	0.0148	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—REST—age related macular degeneration	0.0111	0.0114	CbGpPWpGaD
Pranlukast—NFKB1—IL1-mediated signaling events—SQSTM1—age related macular degeneration	0.0107	0.011	CbGpPWpGaD
Pranlukast—IL5—connective tissue—age related macular degeneration	0.0106	0.376	CbGeAlD
Pranlukast—IL5—Signaling by Interleukins—SQSTM1—age related macular degeneration	0.0104	0.0108	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—ADAMTS9—age related macular degeneration	0.0101	0.0104	CbGpPWpGaD
Pranlukast—NFKB1—Interleukin-1 signaling—SQSTM1—age related macular degeneration	0.0094	0.00967	CbGpPWpGaD
Pranlukast—TNF—Caspase Cascade in Apoptosis—TNFRSF10A—age related macular degeneration	0.00923	0.0095	CbGpPWpGaD
Pranlukast—TNF—Amyotrophic lateral sclerosis (ALS)—CST3—age related macular degeneration	0.00916	0.00943	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—F13B—age related macular degeneration	0.00905	0.00931	CbGpPWpGaD
Pranlukast—IL5—Allograft Rejection—C3—age related macular degeneration	0.00852	0.00877	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—SERPING1—age related macular degeneration	0.00851	0.00876	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—REST—age related macular degeneration	0.00845	0.00869	CbGpPWpGaD
Pranlukast—NFKB1—TNF receptor signaling pathway —SQSTM1—age related macular degeneration	0.0084	0.00865	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—TNFRSF10A—age related macular degeneration	0.00833	0.00858	CbGpPWpGaD
Pranlukast—MUC2—connective tissue—age related macular degeneration	0.00817	0.289	CbGeAlD
Pranlukast—NFKB1—TGF-beta Receptor Signaling—TGFBR1—age related macular degeneration	0.00815	0.00839	CbGpPWpGaD
Pranlukast—NFKB1—Cardiac Hypertrophic Response—TGFBR1—age related macular degeneration	0.00803	0.00827	CbGpPWpGaD
Pranlukast—TNF—Overview of nanoparticle effects—CRP—age related macular degeneration	0.00785	0.00808	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis-related network due to altered Notch3 in ovarian cancer—SQSTM1—age related macular degeneration	0.0075	0.00772	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—RAD51B—age related macular degeneration	0.00738	0.00759	CbGpPWpGaD
Pranlukast—IL5—AP-1 transcription factor network—CCL2—age related macular degeneration	0.00735	0.00756	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.00734	0.00755	CbGpPWpGaD
Pranlukast—NFKB1—RANKL/RANK Signaling Pathway—SQSTM1—age related macular degeneration	0.00728	0.0075	CbGpPWpGaD
Pranlukast—NFKB1—IL-1 signaling pathway—SQSTM1—age related macular degeneration	0.00728	0.0075	CbGpPWpGaD
Pranlukast—NFKB1—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00719	0.0074	CbGpPWpGaD
Pranlukast—NFKB1—IL1 and megakaryotyces in obesity—CCL2—age related macular degeneration	0.00703	0.00723	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—SLC16A8—age related macular degeneration	0.00686	0.00706	CbGpPWpGaD
Pranlukast—TNF—TNF receptor signaling pathway —SQSTM1—age related macular degeneration	0.0064	0.00659	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—RHO—age related macular degeneration	0.00638	0.00656	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—MAP2—age related macular degeneration	0.00637	0.00655	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00629	0.00647	CbGpPWpGaD
Pranlukast—NFKB1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—age related macular degeneration	0.00624	0.00642	CbGpPWpGaD
Pranlukast—TNF—TGF-beta Receptor Signaling—TGFBR1—age related macular degeneration	0.00621	0.00639	CbGpPWpGaD
Pranlukast—TNF—Cardiac Hypertrophic Response—TGFBR1—age related macular degeneration	0.00612	0.0063	CbGpPWpGaD
Pranlukast—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—SQSTM1—age related macular degeneration	0.00572	0.00588	CbGpPWpGaD
Pranlukast—NFKB1—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00563	0.0058	CbGpPWpGaD
Pranlukast—NFKB1—p75 NTR receptor-mediated signalling—SQSTM1—age related macular degeneration	0.00529	0.00545	CbGpPWpGaD
Pranlukast—NFKB1—IL23-mediated signaling events—CCL2—age related macular degeneration	0.00497	0.00512	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—SQSTM1—age related macular degeneration	0.00488	0.00502	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—MAP2—age related macular degeneration	0.00485	0.00499	CbGpPWpGaD
Pranlukast—NFKB1—eye—age related macular degeneration	0.00483	0.171	CbGeAlD
Pranlukast—CYSLTR1—GPCR ligand binding—RHO—age related macular degeneration	0.00479	0.00493	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—CRP—age related macular degeneration	0.00468	0.00481	CbGpPWpGaD
Pranlukast—NFKB1—connective tissue—age related macular degeneration	0.00466	0.165	CbGeAlD
Pranlukast—NFKB1—Vitamin B12 Metabolism—APOE—age related macular degeneration	0.00458	0.00471	CbGpPWpGaD
Pranlukast—NFKB1—TWEAK Signaling Pathway—CCL2—age related macular degeneration	0.00449	0.00462	CbGpPWpGaD
Pranlukast—IL5—Immune System—C9—age related macular degeneration	0.00446	0.00459	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis-related network due to altered Notch3 in ovarian cancer—APOE—age related macular degeneration	0.00444	0.00457	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00429	0.00442	CbGpPWpGaD
Pranlukast—IL5—Allograft Rejection—VEGFA—age related macular degeneration	0.00428	0.00441	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—SQSTM1—age related macular degeneration	0.00424	0.00437	CbGpPWpGaD
Pranlukast—IL5—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00395	0.00406	CbGpPWpGaD
Pranlukast—IL5—Immune System—CFI—age related macular degeneration	0.00387	0.00398	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—CCL2—age related macular degeneration	0.00385	0.00396	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—CRP—age related macular degeneration	0.0038	0.00392	CbGpPWpGaD
Pranlukast—TNF—IL23-mediated signaling events—CCL2—age related macular degeneration	0.00379	0.0039	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—RHO—age related macular degeneration	0.00377	0.00388	CbGpPWpGaD
Pranlukast—NFKB1—Transcriptional regulation of white adipocyte differentiation—CD36—age related macular degeneration	0.00373	0.00384	CbGpPWpGaD
Pranlukast—NFKB1—IL-1 signaling pathway—CCL2—age related macular degeneration	0.00362	0.00373	CbGpPWpGaD
Pranlukast—IL5—Immune System—CFHR3—age related macular degeneration	0.0036	0.0037	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—TGFBR1—age related macular degeneration	0.00358	0.00369	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—CRP—age related macular degeneration	0.00356	0.00367	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—APOE—age related macular degeneration	0.00349	0.00359	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—SQSTM1—age related macular degeneration	0.00347	0.00357	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—RHO—age related macular degeneration	0.00342	0.00352	CbGpPWpGaD
Pranlukast—TNF—TWEAK Signaling Pathway—CCL2—age related macular degeneration	0.00342	0.00352	CbGpPWpGaD
Pranlukast—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—APOE—age related macular degeneration	0.00338	0.00348	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—SQSTM1—age related macular degeneration	0.00337	0.00347	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.0033	0.0034	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—RDH8—age related macular degeneration	0.0033	0.0034	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TGFBR1—age related macular degeneration	0.00329	0.00338	CbGpPWpGaD
Pranlukast—IL5—Immune System—C2—age related macular degeneration	0.00321	0.0033	CbGpPWpGaD
Pranlukast—NFKB1—MyD88:Mal cascade initiated on plasma membrane—CD36—age related macular degeneration	0.00318	0.00327	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—CCL2—age related macular degeneration	0.00317	0.00326	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—CCL2—age related macular degeneration	0.00313	0.00322	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—C9—age related macular degeneration	0.00311	0.0032	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00302	0.00311	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00297	0.00305	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—CCL2—age related macular degeneration	0.00293	0.00302	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—CRP—age related macular degeneration	0.0029	0.00298	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—RPE65—age related macular degeneration	0.00288	0.00297	CbGpPWpGaD
Pranlukast—TNF—Transcriptional regulation of white adipocyte differentiation—CD36—age related macular degeneration	0.00284	0.00292	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—TLR4—age related macular degeneration	0.0028	0.00288	CbGpPWpGaD
Pranlukast—NFKB1—MyD88:Mal cascade initiated on plasma membrane—TLR4—age related macular degeneration	0.00275	0.00283	CbGpPWpGaD
Pranlukast—NFKB1—Activated TLR4 signalling—CD36—age related macular degeneration	0.00274	0.00282	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—RHO—age related macular degeneration	0.00271	0.00278	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CFI—age related macular degeneration	0.0027	0.00278	CbGpPWpGaD
Pranlukast—NFKB1—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00268	0.00276	CbGpPWpGaD
Pranlukast—IL5—Immune System—CFH—age related macular degeneration	0.00268	0.00276	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—SQSTM1—age related macular degeneration	0.00264	0.00272	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—C3—age related macular degeneration	0.00264	0.00272	CbGpPWpGaD
Pranlukast—NFKB1—MyD88-independent cascade—TLR4—age related macular degeneration	0.00264	0.00271	CbGpPWpGaD
Pranlukast—IL5—Immune System—CFB—age related macular degeneration	0.0026	0.00268	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—CD36—age related macular degeneration	0.00258	0.00266	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—TLR4—age related macular degeneration	0.00257	0.00265	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00252	0.00259	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CFHR3—age related macular degeneration	0.00251	0.00258	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TGFBR1—age related macular degeneration	0.00251	0.00258	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00249	0.00256	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—RHO—age related macular degeneration	0.00246	0.00253	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—APOE—age related macular degeneration	0.00246	0.00253	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—CCL2—age related macular degeneration	0.0024	0.00247	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—CCL2—age related macular degeneration	0.00238	0.00245	CbGpPWpGaD
Pranlukast—NFKB1—Activated TLR4 signalling—TLR4—age related macular degeneration	0.00237	0.00244	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—SQSTM1—age related macular degeneration	0.00237	0.00244	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RDH8—age related macular degeneration	0.00237	0.00244	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ABCA4—age related macular degeneration	0.00233	0.00239	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—CRP—age related macular degeneration	0.0023	0.00237	CbGpPWpGaD
Pranlukast—NFKB1—Toll-Like Receptors Cascades—CD36—age related macular degeneration	0.0023	0.00237	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00226	0.00233	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—C2—age related macular degeneration	0.00224	0.0023	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—TLR4—age related macular degeneration	0.00223	0.0023	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—CCL2—age related macular degeneration	0.00222	0.00229	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RPE65—age related macular degeneration	0.00207	0.00213	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00204	0.0021	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—CD36—age related macular degeneration	0.00204	0.00209	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—VEGFA—age related macular degeneration	0.00203	0.00209	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00203	0.00209	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—RHO—age related macular degeneration	0.00202	0.00208	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—TLR4—age related macular degeneration	0.00201	0.00207	CbGpPWpGaD
Pranlukast—NFKB1—Toll-Like Receptors Cascades—TLR4—age related macular degeneration	0.00199	0.00205	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—SQSTM1—age related macular degeneration	0.00198	0.00204	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—TLR4—age related macular degeneration	0.00196	0.00202	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—SQSTM1—age related macular degeneration	0.00195	0.002	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00192	0.00198	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00189	0.00195	CbGpPWpGaD
Pranlukast—IL5—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00188	0.00194	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CFH—age related macular degeneration	0.00187	0.00193	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—CCL2—age related macular degeneration	0.00183	0.00188	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CFB—age related macular degeneration	0.00181	0.00187	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—C9—age related macular degeneration	0.00181	0.00187	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TLR4—age related macular degeneration	0.00175	0.0018	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00171	0.00176	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00171	0.00176	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ABCA4—age related macular degeneration	0.00167	0.00172	CbGpPWpGaD
Pranlukast—IL5—Immune System—SQSTM1—age related macular degeneration	0.00159	0.00164	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00159	0.00164	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CFI—age related macular degeneration	0.00157	0.00162	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—C3—age related macular degeneration	0.00155	0.00159	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—TLR4—age related macular degeneration	0.00153	0.00158	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—CCL2—age related macular degeneration	0.0015	0.00154	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CFHR3—age related macular degeneration	0.00146	0.0015	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RHO—age related macular degeneration	0.00145	0.00149	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RDH8—age related macular degeneration	0.00134	0.00138	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—VEGFA—age related macular degeneration	0.00133	0.00136	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—C2—age related macular degeneration	0.0013	0.00134	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—C3—age related macular degeneration	0.00122	0.00125	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CCL2—age related macular degeneration	0.00121	0.00125	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RPE65—age related macular degeneration	0.00117	0.00121	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TGFBR1—age related macular degeneration	0.00114	0.00117	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—C3—age related macular degeneration	0.00111	0.00114	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CFH—age related macular degeneration	0.00109	0.00112	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD36—age related macular degeneration	0.00107	0.0011	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CFB—age related macular degeneration	0.00106	0.00109	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	0.00104	0.00107	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SQSTM1—age related macular degeneration	0.00103	0.00106	CbGpPWpGaD
Pranlukast—IL5—Immune System—C3—age related macular degeneration	0.00101	0.00104	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00101	0.00104	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000982	0.00101	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—VEGFA—age related macular degeneration	0.000969	0.000998	CbGpPWpGaD
Pranlukast—IL5—Immune System—CRP—age related macular degeneration	0.000962	0.00099	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ABCA4—age related macular degeneration	0.000945	0.000972	CbGpPWpGaD
Pranlukast—IL5—Immune System—TLR4—age related macular degeneration	0.000923	0.000949	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—C3—age related macular degeneration	0.000875	0.0009	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CCL2—age related macular degeneration	0.000866	0.000892	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000859	0.000884	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000846	0.000871	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—CD36—age related macular degeneration	0.000843	0.000868	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RHO—age related macular degeneration	0.000822	0.000846	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000815	0.000839	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—C3—age related macular degeneration	0.000795	0.000818	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.000769	0.000792	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CD36—age related macular degeneration	0.000745	0.000766	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000739	0.00076	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—KDR—age related macular degeneration	0.000729	0.00075	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD36—age related macular degeneration	0.000715	0.000736	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—C3—age related macular degeneration	0.000706	0.000726	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—C3—age related macular degeneration	0.000678	0.000697	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CRP—age related macular degeneration	0.000671	0.000691	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—VEGFA—age related macular degeneration	0.000663	0.000682	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000654	0.000673	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—C3—age related macular degeneration	0.000654	0.000673	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—SQSTM1—age related macular degeneration	0.000647	0.000666	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—TLR4—age related macular degeneration	0.000644	0.000662	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CD36—age related macular degeneration	0.000642	0.000661	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CCL2—age related macular degeneration	0.000622	0.00064	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—APOE—age related macular degeneration	0.000609	0.000627	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—KDR—age related macular degeneration	0.000596	0.000614	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—KDR—age related macular degeneration	0.000555	0.000571	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCL2—age related macular degeneration	0.000512	0.000527	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	0.0005	0.000515	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—C3—age related macular degeneration	0.000469	0.000483	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000461	0.000475	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	0.000437	0.00045	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—APOE—age related macular degeneration	0.000437	0.00045	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD36—age related macular degeneration	0.000434	0.000446	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—KDR—age related macular degeneration	0.000428	0.000441	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000418	0.000431	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—C3—age related macular degeneration	0.000411	0.000423	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000405	0.000417	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—VEGFA—age related macular degeneration	0.000402	0.000413	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CRP—age related macular degeneration	0.000391	0.000402	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000391	0.000402	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TLR4—age related macular degeneration	0.000375	0.000386	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCL2—age related macular degeneration	0.000367	0.000378	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.000353	0.000363	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.00033	0.00034	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—VEGFA—age related macular degeneration	0.000329	0.000338	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—VEGFA—age related macular degeneration	0.000306	0.000315	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000288	0.000297	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—C3—age related macular degeneration	0.000266	0.000273	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APOE—age related macular degeneration	0.000247	0.000255	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KDR—age related macular degeneration	0.000242	0.000249	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—VEGFA—age related macular degeneration	0.000236	0.000243	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000235	0.000242	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000233	0.000239	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL2—age related macular degeneration	0.000208	0.000214	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000207	0.000213	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—LIPC—age related macular degeneration	0.00018	0.000186	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CETP—age related macular degeneration	0.000174	0.000179	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VEGFA—age related macular degeneration	0.000134	0.000137	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.000119	0.000123	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CETP—age related macular degeneration	0.000115	0.000118	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CD36—age related macular degeneration	0.000105	0.000108	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOE—age related macular degeneration	9.23e-05	9.5e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CD36—age related macular degeneration	6.9e-05	7.1e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOE—age related macular degeneration	6.09e-05	6.27e-05	CbGpPWpGaD
